Jefferies Financial lowered the target price of Novavax from $38 to $31 and maintained a "buy" rating.
杰富瑞下调诺瓦瓦克斯医药目标价至31美元
Jefferies Financial lowered the target price for Novavax to $31.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.